Tuberculous meningitis in adults: A four-year review during 1997-2000

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 34, Issue 4, 2003, Pages 869-871

  Chotmongkol, Verajit ^a   Panthavasit, Jedsada ^a   Tiamkao, Somsak ^a   Jitpimolmard, Suthipun ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID;

ADOLESCENT; ADULT; ADULTHOOD; AGED; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HUMAN; MALE; MEDICAL RECORD; MORTALITY; NEUROLOGIC DISEASE; REVIEW; THAILAND; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS;

EID: 1842684416     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. Chotmongkol V. Treatment of tuberculous meningitis with 6-month course of chemotherapy. Southeast Asian J Trop Med Public Health 1991; 22: 372-4.
2. Chotmongkol V, Jitpimolmard S, Thavornpitak Y. Corticosteroid in tuberculous meningitis. J Med Assoc Thai 1996; 79: 83-90.
3. Gordon A, Parsons M. The place of corticosteroids in the management of tuberculous meningitis. Br J Hosp Med 1972; 7: 651-5.
4. Hosoglu S, Geyik MF, Balik I, et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 2002; 6: 64-70.
5. Parsad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. Cochrance Database Syst Rev 2000; 3: CD002244.
6. Van Loenhout-Rooyackers JH, Keyser A, Laheij RJ, Verbeek AL, van der Meer JW. Tuberculous meningitis: is a 6-month treatment regimen sufficient? Int J Tuberc Lung Dis 2001; 5: 1028-35.